)
Sensorion (ALSEN) investor relations material
Sensorion H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Advanced gene therapy pipeline with SENS-501 and GJB2-GT, targeting congenital hearing loss.
Achieved key clinical milestones, including positive safety and early efficacy signals for SENS-501.
Strengthened financial position with €60m financing, including €20m from Sanofi, extending cash runway to end of H1 2027.
Leadership transition with Amit Munshi appointed as Chairman and Interim CEO following the departure of the previous CEO.
Financial highlights
Cash and cash equivalents at €47.5m as of December 31, 2025, down from €77.0m at year-end 2024.
R&D expenses increased 12% year-over-year to €28.8m in 2025.
G&A expenses decreased to €7.7m from €9.4m in 2024.
Net loss widened to -€29.4m in 2025 from -€26.0m in 2024.
Outlook and guidance
Sufficient net working capital to meet cash requirements until end of June 2027.
SENS-501 six-month efficacy data expected in Q1 2026; GJB2-GT CTA submission on track for H1 2026.
- Gene therapy pipeline advances with early clinical success and strong strategic partnerships.ALSEN
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Key clinical milestones and regulatory progress position the pipeline for major updates in 2024.ALSEN
Investor Update28 Nov 2025 - Strong clinical pipeline progress and solid cash position, despite higher net loss.ALSEN
H1 202517 Sep 2025 - Gene therapies and small molecules advance toward key milestones in hearing loss treatment.ALSEN
Corporate Presentation4 Jul 2025 - Sensorion achieved major clinical milestones and secured €87.3m to fund operations into 2025.ALSEN
H1 202413 Jun 2025 - Advancing gene therapies and small molecules, Sensorion targets global leadership in hearing loss.ALSEN
Corporate Presentation13 Jun 2025 - Sensorion advances gene therapies and SENS-401 for hearing loss, targeting major clinical milestones.ALSEN
Corporate Presentation6 Jun 2025 - Sensorion achieved major clinical milestones and secured €65.5m, funding operations into 2026.ALSEN
H2 20245 Jun 2025
Next Sensorion earnings date
Next Sensorion earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)